# MEWDS-like Presentation Unmasking Sequential Bilateral Multifocal Choroiditis: Insights from Longitudinal Multimodal Imaging

**Authors:** Blerta Lang, Annekatrin Rickmann, Karl Thomas Boden, Stefanie Behnke, Peter Szurman

PMC · DOI: 10.3390/biomedicines14030649 · Biomedicines · 2026-03-13

## TL;DR

A patient initially diagnosed with MEWDS-like symptoms was later found to have sequential bilateral multifocal choroiditis through long-term imaging and treatment tracking.

## Contribution

This case highlights longitudinal multimodal imaging's role in reclassifying MEWDS-like presentations to sequential bilateral multifocal choroiditis.

## Key findings

- Initial MEWDS-like presentation evolved into sequential bilateral multifocal choroiditis over 4 years.
- Longitudinal multimodal imaging revealed key diagnostic changes, including peripapillary inflammation and macular edema.
- No choroidal neovascularization developed, avoiding anti-VEGF therapy.

## Abstract

Background: Multiple evanescent white dot syndrome (MEWDS) is usually acute and self-limited, whereas multifocal choroiditis (MFC)/punctate inner choroidopathy (PIC) is relapsing; overlap can obscure early diagnosis and requires longitudinal multimodal imaging. Methods: We report a 4-year follow-up of a 31-year-old woman with fundus autofluorescence (FAF), fluorescein angiography (FA), indocyanine green angiography (ICGA), and spectral-domain optical coherence tomography (SD-OCT), plus a systemic/neurologic/rheumatologic work-up. Treatment included intravenous methylprednisolone for presumed optic neuritis, followed by topical, periocular, intravitreal, and systemic corticosteroids, later escalated to adalimumab and an intravitreal dexamethasone implant. Because foveal granularity could not be documented, baseline was termed “MEWDS-like”. Diagnostic labelling was benchmarked against Standardization of Uveitis Nomenclature (SUN) criteria, and choroidal neovascularization (CNV) was assessed at each relapse by OCT and FA. Results: The right eye initially showed a MEWDS-like pattern with wreath-like FA lesions and disc leakage, hyperautofluorescent FAF lesions, focal ellipsoid zone disruption on SD-OCT, and multifocal ICGA hypofluorescent spots. A relapse at 6 months with peripapillary inflammatory foci and recurrent cystoid macular edema supported reclassification to a unilateral MFC/PIC-spectrum phenotype. At 2 years, the fellow eye developed mild vitritis, peripapillary hyperautofluorescence, peripapillary/arcade leakage on FA, delayed peripapillary filling on ICGA, and cystoid macular edema, establishing sequential bilateral MFC; no CNV developed and anti-vascular endothelial growth factor (anti-VEGF) therapy was not required. Complications included steroid-induced ocular hypertension and cataract surgery. Conclusions: The purpose of this report is to highlight longitudinal imaging “red flags” that supported reclassification from a MEWDS-like phenotype to a sequential bilateral MFC/PIC-spectrum disease.

## Linked entities

- **Chemicals:** methylprednisolone (PubChem CID 6741), dexamethasone (PubChem CID 5743)
- **Diseases:** multifocal choroiditis (MONDO:0023833), punctate inner choroidopathy (MONDO:0035584), uveitis (MONDO:0020283), cystoid macular edema (MONDO:0007935), ocular hypertension (MONDO:0006875), cataract (MONDO:0005129)

## Full-text entities

- **Genes:** VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}
- **Diseases:** inflammatory (MESH:D007249), ocular hypertension (MESH:D009798), cystoid macular edema (MESH:D008269), CNV (MESH:D020256), cataract (MESH:D002386), MFC (MESH:D000080364), optic neuritis (MESH:D009902), MEWDS (MESH:D000080363)
- **Chemicals:** adalimumab (MESH:D000068879), fluorescein (MESH:D019793), indocyanine green (MESH:D007208), steroid (MESH:D013256), dexamethasone (MESH:D003907), methylprednisolone (MESH:D008775)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13024056/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13024056/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC13024056/full.md

---
Source: https://tomesphere.com/paper/PMC13024056